Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
Lung cancer screening has increased the finding of early stage lung cancers with an 80% of stage I and II diagnosed cancer that can be treated by minimally-invasive surgery. This video presentation evaluates the use of robotic surgery in the treatment of screening detected lung cancer in early stage.
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC
SIOG 2024: Updates in medical oncology
Laser oncosurgery - A new perspective in treating cancer
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
ESMO 2024: Highlights and analysis